Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

PHASE4CompletedINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Asthma

Interventions

DRUG

Fluticasone/Salmeterol HFA

Fluticasone/Salmeterol HFA, 2 puffs twice daily

Trial Locations (4)

GSK Investigational Site, Kippa-Ring

GSK Investigational Site, Auchenflower

GSK Investigational Site, Caboolture

GSK Investigational Site, Perth